· HI legislature · 2026

RELATING TO TERMINAL ILLNESSES.

Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions. Effective 12/31/2050. (SD1)

Sponsor

Kurt Fevella (R-HI)

Introduced

2025-12-08

Policy area

Health

Latest action

Pending Introduction.